Navigation Links
Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus

Using multi-disciplinary analysis that included cognitive, neurophysiologic, virologic, and molecular techniques, the team found both a low-level viral infection in the brain and immune cells that had infiltrated the brain in order to protect against the virus.

"As in the rest of the body, in the brain immune cells achieve a level of control of the virus, but are unable to clear the infection," says Howard Fox, associate professor at Scripps Research and director of Scripps NeuroAIDS Preclinical Studies center, who led the study. "Over the long-term, this immune response may act as a double-edged sword, protecting against rampant viral replication in the brain but leading to brain dysfunction."

The paper was published in the April 26 issue of the Journal of Neuroscience, the official journal of the Society of Neuroscience.

The study addresses a significant health problem. About one quarter to one third of all AIDS patients suffer from some form of central nervous system disorder in the course of their infection, ranging from minor cognitive and motor disorders to severe dementia, collectively known as neuroAIDS. Even subtle neurocognitive disorders limit quality of life with symptoms such as fatigue, and are correlated with difficulties ranging from a higher rate of traffic tickets to increased mortality.

In recent years, access to potent antiretroviral drugs in the United States and other developed countries has significantly improved the health, survival, and functioning of HIV-infected individuals. But since people are living longer with the virus, the overall prevalence of neuroAIDS appears to be increasing.

"Now that we're better at treating the immune/viral aspect of HIV, in many ways [AIDS] has turned into a chronic disease," says Fox. "The fact that many of the antiretroviral drugs do not show good penetration of the blood-brain barrier further puts the brain at risk, since the brain is infected soon after HIV exposu
'"/>

Source:Public Health Agency of Canada


Page: 1 2

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. Experimental shingles vaccine proves effective in nationwide study
3. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
4. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
5. Experimental RNA-based drug kills prostate cancer cells effectively and safely
6. Experimental vaccine protects lab animals against several strains of H5N1
7. Experimental vaccine protects mice against deadly 1918 flu virus
8. Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy
9. Experimental vaccine given during pregnancy reduces stillbirths from common virus
10. Research advances quest for HIV-1 vaccine
11. A much-needed shot in the arm for HIV vaccine development

Post Your Comments:
(Date:11/8/2009)... a gene through deletion of genetic material on ch...lities in learning and behavior, said a consortium...( www.bcm.edu ) in a report that appears online to...search goes about 95 percent of the way to pinning... to this gene," said Dr. Arthur L. Beaudet ( http:...
(Date:11/6/2009)...mony with their arboreal hosts. But new research s...rees of choice, the ants can get destructive to ne...e November issue of the American Naturalist , is ...es, and it reopens a centuries-old debate on the r...certain species of plants and trees have cozy rela...
(Date:11/5/2009)...ersity have developed synthetic molecules capable ... HIV-infected cells, as well as to prostate cancer...ournal of the American Chemical Society , could le...ses. , The molecules called "antibody-recruiti...ecruiting molecule targeting prostate cancer" (ARM...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 1Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 2Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 3DNA Diagnostics Center Offers Father 26apos 3Bs Day DNA Testing 12638 1DNA Diagnostics Center Offers Father 26apos 3Bs Day DNA Testing 12638 2Executive Shares His Story in an Effort to Save Lives 48994 1Executive Shares His Story in an Effort to Save Lives 48994 2
...lar biophysics and biochemistry at Yale has recei...dation to expand research on the delivery of a tar...les. , Garen and his collaborator Zhiwei Hu hav...he blood vessels of solid tumors, thus destroying ... , The technology uses a synthetic gene encoding...
... with a drug compound substantially improved learn..., say researchers at the Stanford University Schoo...al. What’s more, the gains lasted for months after...re now considering a clinical trial to test whethe... Down syndrome. , "This treatment has remarkable p...
...uld help control weight, lower fat and cholesterol...ports Lisa Richards in Chemistry & Industry, t...been hailed for its cholesterol lowering capabilit...nufacturer Birds Eye has added the beans to its ra...wn that black soya may be even more potent in rats...
Other Biology News:Nanoparticles for delivery of prostate cancer treatment 2Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 2Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 3Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows 4
(Date:11/5/2009)...wire/ -- The endangered black-footed ferrets inhab...e carnivore feeds on prairie dogs. The prairie d...e population die-offs in towns occur. The U.S. Fi...ferret breeding program and has been releasing tra...abitat. Unfortunately, plague can sweep through a...
(Date:11/5/2009)...irstCall/ -- Transgenomic, Inc. (OTC Bulletin Boar... quarter ended September 30, 2009. The Company,s f...follow. ,, Third Quarter 2009 ,, The Compa...are for the third quarter of 2009 as compared to a...hird quarter of 2008. ,, Net sales were $5.0 m...
(Date:11/5/2009)...re-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bu...of-the-art genetic analysis systems, today announc...mpany,s Scientific Advisory Board. His career has...el molecular diagnostics for cancer detection and ...utational biology systems for several biotechnolog...
(Date:11/5/2009)...s brings a new look to Pro Repro , ...rofessional Reprographics, Orange County’s f... present Brooke Sanders to the company. Brooke joi...e addition of Brooke to the company represents con...eprographics., , ,Brooke brings with her over five...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...linary team of Cornell nanotechnology researchers ... material that holds promise for light-emitting, f...lved years of perfecting a technique for building ...ted in the Sept. 30 online publication of the jour...m had long studied the molecular semiconductor rut...
...ct. 9 Thermo Fisher,Scientific Inc. (NYSE: TMO )...nced it has acquired NanoDrop Technologies, LLC, a...visible (UV-Vis) instrumentation.,The acquisition ...s,spectrophotometry instruments for applications i...volume samples are used in emerging life,sciences ...
..., Oct. 9 Pharmaceutical and biotech,companies rea... they ensure,strong partnerships between R&D and m...mmercial focus in all stages of product developmen...that have traditionally,separated R&D from marketi...nted medical researchers and skillful marketers. ...
Other Biology Technology:CU researchers shed light on light-emitting nanodevice 2Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies 2Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies 3Pharmaceutical Product Launch: Commercially Focused R&D Increases Drug's Market Potential 2
...ilZyme AP Conjugate Stabilizer is an aqueous solut...her non-toxic stabilizing chemicals in a MES buffe... This product contains a combination of 0.02% met...preservative. StabilZyme AP Conjugate Stabilizer ...
Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.
... nonspecific binding is a problem in your applicat...vidin products as superior alternatives to avidin ...derivative that combines several key features to p... low nonspecific binding properties. NeutrAvidin d...
BlueView Nucleic Acid Stain from Sigma-Aldrich
Biology Products: